• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall smiths medical medex CBSS5ML, Double set

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall smiths medical medex CBSS5ML, Double set see related information
Date Initiated by Firm March 10, 2020
Create Date October 13, 2021
Recall Status1 Terminated 3 on September 22, 2023
Recall Number Z-0103-2022
Recall Event ID 88667
Product Classification Pacemaker, cardiac, external transcutaneous (non-invasive) - Product Code DRO
Product smiths medical medex CBSS-5ML, Double set, (172+15cm), Model Number DPSHC0094
Code Information All codes
Recalling Firm/
Manufacturer
Smiths Medical ASD Inc.
6000 Nathan Ln N
Minneapolis MN 55442-1690
For Additional Information Contact Dave Halverson
763-383-3310
Manufacturer Reason
for Recall
Reported pressure shifts and incorrect pressure readings in LogiCal Closed Blood Sampling System sets.
FDA Determined
Cause 2
Component design/selection
Action The firm initiated the recall by letter during the week of 03/10/2020. The notices requested the direct consignee notify their customers and collect the responses. The firm is seeking return of the products.
Quantity in Commerce 3620 units
Distribution Austria, France, Germany, Great Britain, and Saudi Arabia
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-